Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: BJU Int. 2021 May 24;129(4):463–469. doi: 10.1111/bju.15428

Table 3.

Chemotherapy response rates for those patients with muscle-invasive bladder cancer who received neoadjuvant chemotherapy including patients who had sarcomatoid histology at cystectomy but not on TUR in the sarcomatoid group

UC, NOS, N = 313 Sarcomatoid histology N = 38 P
Response to chemotherapy 0.009
 No response 139 (44%) 27 (71%)
 Partial 98 (31%) 6 (16%)
 Complete 76 (24%) 5 (13%)